Multiple sclerosis: disease-modifying therapies An overview of the available evidence for each disease-modifying therapy for multiple sclerosis, when they are indicated, as well as each stage of patient care.…
Therapy combined with MDMA is effective in treating severe PTSD, phase III trial results suggest Researchers concluded that MDMA-assisted therapy was highly efficacious, safe and well tolerated in those suffering from severe post-traumatic stress disorder.…
Lack of pharmacist access to patient records is public safety issue, says outgoing GPhC chair Exclusive: Nigel Clarke said he was sorry he had not made more progress on read and write access to patient records for pharmacists.…
Bespoke rulers invented by hospital pharmacy staff led to 35% reduction in loss of controlled liquid drugs Northampton General Hospital NHS Trust — where the rulers were trialled — says the device could save the NHS £1.2m a year if used across all NHS hospital trusts.…
One in five drugs approved by EMA in 2021 lacked full environmental risk data Exclusive: Analysis of European Medicines data has revealed that 17 marketing authorisations were approved in 2021 despite being submitted with insufficient environmental risk data.…
Nigel Clarke: ‘The pharmacy registration exam needs to be revisited’ As he steps down after eight years at the helm of the pharmacy regulator, Nigel Clarke reflects on his tenure during one of the most challenging times in the history of public health.…
Joyce Challans (1929–2022)On 21 March 2022, Joyce Challans MPharmS, aged 93 years, of Newcastle-Upon-Tyne. Ms Challans registered with the Society in 1951.…
Prepayment scheme for HRT to start in April 2023 A scheme that will enable women to save up to £205 per year on HRT prescriptions will be introduced later than expected.…
NHS England appoints first clinical director for prescribing Tony Avery, professor of primary healthcare at the University of Nottingham, and his team developed the PINCER project to tackle hazardous prescribing.…
First monoclonal antibody treatment approved for prevention of COVID-19 Evusheld is the first monoclonal antibody treatment to be approved as a 'pre-exposure prophylaxis' treatment.…
